{"DataElement":{"publicId":"3104029","version":"1","preferredName":"Laboratory Procedure Estrogen Receptor Positive Cell Result Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"The 0 decimal place numeric laboratory value measured, assigned or computed related to the assessment of estrogen receptor positive cells in a specimen.","longName":"2646383v1.0:3061015v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2646383","version":"1","preferredName":"Laboratory Procedure Estrogen Receptor Positive Cell Result","preferredDefinition":"information related to the result of a medical procedure that involves testing a blood or tissue specimen for cells of a widely expressed human Estrogen Receptors (NR3 Family) are cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain.","longName":"LAB_ER_P_C_RSLT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2738953","version":"1","preferredName":"ER Positive Cell Result","preferredDefinition":"Widely expressed human Estrogen Receptors (NR3 Family) are ligand-activated nuclear hormone receptor transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI):Involving advantage or good.:The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C17069:C25246:C12508:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Family","conceptCode":"C17069","definition":"Widely expressed human Estrogen Receptors (NR3 Family) are cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49FDE9EF-9982-04CA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-03","modifiedBy":"ONEDATA","dateModified":"2008-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31DF1EDF-C774-5B8A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-01","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-01","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3061015","version":"1","preferredName":"Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A fraction or ratio with 100 understood as the denominator._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"3061015v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3061014","version":"1","preferredName":"Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.:Percentage; a fraction or ratio with 100 understood as the denominator.:A number with no fractional part.::0:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C25294:C20200:C25613:C45255::0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8446A1A4-4444-2A88-E040-BB89AD43255A","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"WHITES","dateCreated":"2010-04-15","modifiedBy":"ONEDATA","dateModified":"2010-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8446A1A4-4455-2A88-E040-BB89AD43255A","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"WHITES","dateCreated":"2010-04-15","modifiedBy":"NYCHM","dateModified":"2010-12-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5542681","version":"1","longName":"EDRN_CDE_Project","context":"EDRN","ClassificationSchemeItems":[{"publicId":"5543567","version":"1","longName":"Reused-CDEs","context":"EDRN"},{"publicId":"5542682","version":"1","longName":"Biospecimen CDEs","context":"EDRN"}]}],"AlternateNames":[{"name":"bc_base_diag_est_recp_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"EDRN","type":"USED_BY","context":"EDRN"},{"name":"Reused-CDEs.Laboratory_Procedure.SPECIMEN_TISSUE_ESTROGENNUCLEARSTAINPERCENT_VALUE_1673","type":"UML Qualified Attr","context":"EDRN"},{"name":"Laboratory_Procedure:SPECIMEN_TISSUE_ESTROGENNUCLEARSTAINPERCENT_VALUE_1673","type":"UML Class:UML Attr","context":"EDRN"}],"ReferenceDocuments":[{"name":"ER % cells stained positive:","type":"Preferred Question Text","description":"ER % cells stained positive:","url":null,"context":"NHLBI"},{"name":"Specify percentage of positive estrogen receptors:","type":"Alternate Question Text","description":"Specify percentage of positive estrogen receptors:","url":null,"context":"NHLBI"},{"name":"What is the percentage of estrogen receptor positive cells?","type":"Alternate Question Text","description":"What is the percentage of estrogen receptor positive cells?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"87A96887-F52A-79EB-E040-BB89AD433CEE","latestVersionIndicator":"Yes","beginDate":"2010-05-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2010-05-28","modifiedBy":"KUMMEROA","dateModified":"2021-08-17","changeDescription":". 2021-8-17 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}